Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Additional Information (Details)

v3.22.1
Stockholders' Equity - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Jan. 01, 2022
Jan. 01, 2021
Mar. 17, 2015
Sep. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Nov. 30, 2020
Jun. 30, 2020
Jun. 04, 2020
Nov. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common stock, shares authorized         135,000,000 95,000,000     135,000,000  
Common Stock, Increase in authorized shares (in shares)                 40,000,000  
Common stock, par or stated value per share         $ 0.0001 $ 0.0001     $ 0.0001  
Common stock, shares issued         77,574,405 62,420,439        
Common stock, shares outstanding         77,574,405 62,420,439        
Shelf registration statement, maximum authorized securities                   $ 100,000
Percentage of annual equity fee     2.50%              
Stock issued during period shares common shares for at the market offering         0 0        
Issuance of common shares, net of offering costs - At-the-market offering         $ 40,269 $ 12,393        
Issuance of common shares - Founders Agreement         1,033 $ 901        
Shelf registration statement remaining authorized securities         54,600          
Total unrecognized compensation cost related to non-vested         $ 3,000          
Non-vested Restricted Stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Weighted average period (in years)         1 year 10 months 24 days          
Performance Shares                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Restricted stock outstanding non-vested         433,334          
2015 Incentive Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares available for issuance Authorized               9,000,000    
Plans expires (in years)         10 years          
Shares are available for issuance         3,025,119          
At the Market Offering                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Commission rate                   3.00%
Number of shares sold         11,899,983          
Sale price per share         $ 3.47          
Aggregate total gross proceeds from shares sold         $ 41,300          
Net proceeds from the offering         $ 40,300          
Underwritten Public Offering                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares sold       7,321,429            
Sale price per share       $ 2.80            
Aggregate total gross proceeds from shares sold       $ 20,500            
Net proceeds from the offering       18,900            
Underwriting discounts and offering expenses       $ 1,600            
Fortress Biotech, Inc                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares sold 2,121,422 1,742,449     297,490 310,625        
Percentage of annual equity fee 2.50% 2.50%                
Percentage of annual equity fee 2.50% 2.50%     2.50%          
Issuance of common shares - Founders Agreement         $ 1,000 $ 900        
Agent                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Shelf registration statement, maximum authorized securities             $ 100,000      
Commission rate             3.00%      
Common Shares                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Sale price per share         $ 3.47 $ 2.50        
Stock issued during period shares common shares for at the market offering         11,899,983 5,104,234        
Stock issued during period value common shares for at the market offering gross         $ 41,300 $ 12,800        
Issuance of common shares, net of offering costs - At-the-market offering         2 0        
Issuance of common shares - Founders Agreement         $ 0 $ 0        
Common Class A                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common stock, shares authorized                 7,000,000  
Common stock, shares issued         7,000,000 7,000,000        
Common stock, shares outstanding         7,000,000 7,000,000